Mar 13, 2018
Phase 1 clinical trial for Hantavirus vaccines yields positive interim results
Feb 01, 2018
Panacea Pharmaceuticals Completes Enrollment in Phase 1 Study of First-in-Class Cancer Vaccine Therapy in Patients with Persistent Prostate Cancer
Jan 09, 2018
Zika Virus vaccine shows significantly higher immune response with Needle-free delivery
Dec 07, 2017
Non-antibody Protein Scaffolds Drugs and Diagnostics Market, 2030 - 25+ Unique Non-antibody Protein Scaffolds Have Been Developed for the Generation of Different Product Candidates
Dec 05, 2017
Success of mRNA Rabies Vaccine Human Study linked to Needle-free Injection
Nov 14, 2017
Replimune Announces First Patients Dosed in a Phase 1/2 Clinical Trial of its RP1 Oncolytic Immunotherapy in Patients With Advanced Solid Tumors
Oct 23, 2017
Publication in npj Vaccines Demonstrates CureVac's RNActive® Vaccine is Superior to Licensed Vaccines
Oct 04, 2017
LakePharma Announces Antibody Collaboration & License Agreement with XOMA
Sep 25, 2017
EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology
Aug 22, 2017
Feldan Therapeutics Announces Issuance of First Patent for its Peptide-Based Protein Delivery Technology, the Feldan Shuttle
Jul 26, 2017
CureVac Announces Publication in The Lancet of First-Ever Human Proof-of-Concept Study Investigating the Safety and Immunogenicity of a Prophylactic mRNA Vaccine
Jul 25, 2017
Biotech Sector Continued Resurgence Fueled by Increasing Clinical Trial Activity & Business Friendly FDA Leadership
Jul 21, 2017
Reminder: Novavax to Host an RSV F Vaccine Update Conference Call and Webcast on July 24, 2017 at 4:30 PM
Jun 21, 2017
GSK presents positive results from Phase III revaccination study of its candidate shingles vaccine Shingrix at CDC's Advisory Meeting
Jun 07, 2017
AFFiRiS Announces Top Line Results of First-in-Human Clinical Study Using AFFITOPE® PD03A, Confirming Immunogenicity and Safety Profile in Parkinson's Disease Patients